Search Results - "Hysek, C M"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA ("Ecstasy") in Humans by Hysek, CM, Simmler, LD, Ineichen, M, Grouzmann, E, Hoener, MC, Brenneisen, R, Huwyler, J, Liechti, ME

    Published in Clinical pharmacology and therapeutics (01-08-2011)
    “…This study assessed the pharmacodynamic and pharmacokinetic effects of the interaction between the selective norepinephrine (NE) transporter inhibitor…”
    Get full text
    Journal Article
  2. 2

    Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans by Hysek, CM, Schmid, Y, Rickli, A, Simmler, LD, Donzelli, M, Grouzmann, E, Liechti, ME

    Published in British journal of pharmacology (01-08-2012)
    “…BACKGROUND AND PURPOSE The use of ±3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is associated with cardiovascular complications and hyperthermia…”
    Get full text
    Journal Article
  3. 3

    Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy) by Hysek, C M, Vollenweider, F X, Liechti, M E

    Published in Emergency medicine journal : EMJ (01-08-2010)
    “…MDMA (3,4-methylenedioxymethamphetamine, 'Ecstasy') produces tachycardia and hypertension and is rarely associated with cardiovascular and cerebrovascular…”
    Get more information
    Journal Article